In contrast, herein we evidenced that HL-60 cells are similarly sensitive to CIGB-300-induced cell death when compared with OCI-AML3, thus suggesting the existence of a divergent mechanism of action for each CK2 inhibitor in AML cells. Here, RUNX2 is linked to acute myeloid leukemia.